Thousands more people with advanced bowel cancer to benefit as NICE approves bevacizumab biosimilars
NICE has today published final draft guidance recommending bevacizumab with chemotherapy for people with metastatic colorectal cancer. This is the first time NICE has been able to recommend ...
Dec 31 (Reuters) - Outlook Therapeutics (OTLK.O), opens new tab said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, dealing another blow in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback